PwC: 2012's economic, political uncertainties will be game-changers for biopharma
This article was originally published in Scrip
Executive Summary
With the US presidential election, the anticipated Supreme Court ruling on the 2010 health reform law and the outcome of the congressional "super" committee's deficit cuts all expected to have major impacts on pharmaceutical makers, health care providers and insurers next year, 2012 will be a game-changer for the health care industry, PwC said in its latest annual trends report.